Q4 2023 Eton Pharmaceuticals Inc Earnings Call Transcript

Mar 14, 2024 / 08:30PM GMT
Operator

Good afternoon, and welcome to Eton Pharmaceuticals' fourth quarter 2023 financial results conference call. At this time, all participants are in a listen only mode. Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company's request. At this time, I'd like to turn it over to David Krempa, Chief Business Officer at Eton Pharmaceuticals. Please proceed.

David Krempa - Eton Pharmaceuticals, Inc. - Chief Business Officer

Thank you, operator. Good afternoon, everyone, and welcome to Eaton's Fourth Quarter 2023 conference call. This afternoon, we issued a press release that outlines the topics we plan to discuss on today's call. The release is available on our website, Eaton pharma.com. Joining me on our call today, we have Sean Brynjelsen, our CEO; and James Gruber, our CFO. In addition to taking live questions on today's call, we will be answering questions that were e-mailed to us. Investors can send their questions to Investor Relations at Eaton pharma.com.

Before we begin

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot